Literature DB >> 31076784

Treatment of Moyamoya Disease.

Xiaofeng Deng1,2,3,4,5, Peicong Ge1,2,3,4,5, Shuo Wang1,2,3,4,5, Dong Zhang1,2,3,4,5, Yan Zhang1,2,3,4,5, Rong Wang1,2,3,4,5, Jizong Zhao1,2,3,4,5.   

Abstract

Year:  2018        PMID： 31076784     DOI： 10.1093/neuros/nyy114

Source DB:  PubMed          Journal:  Neurosurgery        ISSN： 0148-396X            Impact factor:   4.654


× No keyword cloud information.
  6 in total

Review 1.  Idiopathic Non-atherosclerotic Carotid Artery Disease.

Authors:  Andrea Harriott
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-14

2.  Postoperative collateral formation after indirect bypass for hemorrhagic moyamoya disease.

Authors:  Peicong Ge; Qian Zhang; Xun Ye; Xingju Liu; Xiaofeng Deng; Jia Wang; Rong Wang; Yan Zhang; Dong Zhang; Jizong Zhao
Journal:  BMC Neurol       Date:  2020-01-17       Impact factor: 2.474

3.  Circulating choline pathway nutrients and risk of moyamoya disease.

Authors:  Peicong Ge; Yaobo Zhao; Yuanren Zhai; Qian Zhang; Xun Ye; Jia Wang; Rong Wang; Yan Zhang; Dong Zhang; Jizong Zhao
Journal:  Front Nutr       Date:  2022-08-01

Review 4.  [Advances in surgical treatment of ischemic cerebrovascular disease].

Authors:  Jianmin Zhang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2019-05-25

5.  Subacute Stroke in a Young Female: A Case of Moyamoya Syndrome Initially Anchoring with Anxiety.

Authors:  Saira Chaughtai; Zeeshan Chaughtai; Muhammad Shaheryar Haider; Hasnan M Ijaz; Sarah Elmedani; Mohamed Bakr; Mohammad A Hossain; Arif Asif
Journal:  Case Rep Med       Date:  2019-12-10

Review 6.  Current Surgical Options for Moyamoya Disease.

Authors:  Julie Mayeku; Miguel A Lopez-Gonzalez
Journal:  Cureus       Date:  2020-11-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.